Skip to search formSkip to main contentSkip to account menu

Circulating Endothelial Cell Count

Known as: CEC, Circulating Endothelial Cells 
The determination of the amount of circulating endothelial cells present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A high voltage-gain LLC micro-converter with high efficiency in wide input range for PV applications
This paper proposes a novel high voltage-gain LLC micro-converter for PV applications. The converter has simple structure and… 
2008
2008
Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage
Summary Increased numbers of circulating endothelial cells (CEC) in peripheral blood have been observed in diseases with vascular… 
Highly Cited
2006
Highly Cited
2006
Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors.
PURPOSE ZD6126 is a novel vascular-targeting agent that induces selective effects on the morphology of endothelial cells by… 
Highly Cited
2006
Highly Cited
2006
Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations
Age and cardiovascular disease status appear to alter numbers and function of circulating endothelial progenitor cells (EPCs… 
Highly Cited
2004
Highly Cited
2004
Copper and zinc sorption by treated oil shale ash
2004
2004
Ecological importance of ambient solar ultraviolet radiation to a sub-arctic heath community
While there is considerable knowledge of the effects of enhanced levelsof ultraviolet radiation (UV) on plant species, much less… 
Review
2002
Review
2002
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute…
BACKGROUND Myocardial (re)infarction (MI), a common trial end point, can be difficult to identify because of inconclusive signs… 
Highly Cited
2001
Highly Cited
2001
Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells.
Vascular endothelial growth factor (VEGF) and nitric oxide (NO) seem to be involved in the process of angiogenesis, but their… 
1999
1999
Sorption and Abiotic Transformation of Aniline and α-Naphthylamine by Surface Soils
Improving the assessment and subsequent remediation of sites contaminated with aromatic amines requires differentiating between… 
Highly Cited
1991
Highly Cited
1991
Variation in Forest Soil Properties along a Great Lakes Air Pollution Gradient
A pronounced air-pollution gradient exists across the Great Lakes region, with deposition of SO₄, NO₃, and H increasing from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)